Dr. Reddy’s Laboratories rolls out Regadenoson Injection in US

TAGS

Indian pharma company Dr. Reddy’s Laboratories said that it has launched 0.4 mg/5 mL in the US market.

Approved by the US Food and Drug Administration (FDA), Regadenoson Injection is a generic therapeutic equivalent of (Regadenoson) injection of .

It is a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI).

Dr. Reddy’s Laboratories’ Regadenoson Injection is available as single-dose pre-filled syringes, 0.4 mg/5 mL (0.08 mg/mL).


Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

CATEGORIES
TAGS
Share This